Johnson & Johnson (NYSE: JNJ) is 2.71% higher on its value in year-to-date trading and has touched a low of $144.95 and a high of $175.97 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The JNJ stock was last observed hovering at around $160.79 in the last trading session, with the day’s gains setting it 0.19%.
Currently trading at $160.98, the stock is 1.85% and 1.56% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.08 million and changing 0.12% at the moment leaves the stock 1.01% off its SMA200. JNJ registered 3.21% gain for a year compared to 6-month loss of -3.17%. The firm has a 50-day simple moving average (SMA 50) of $4.63 and a 200-day simple moving average (SMA200) of $16.90.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 0.93% gain in the last 1 month and extending the period to 3 months gives it a 5.56%, and is 1.98% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.19% over the week and 1.23% over the month.
Johnson & Johnson (JNJ) has around 131900 employees, a market worth around $387.76B and $93.02B in sales. Current P/E ratio is 28.86 and Fwd P/E is 14.64. Profit margin for the company is 15.23%. Distance from 52-week low is 11.06% and -8.52% from its 52-week high. The company has generated returns on investments over the last 12 months (14.80%).
Johnson & Johnson quarterly earnings per share for the current quarter are estimated at $2.63 with sales reaching $21.4B over the same period.The EPS is expected to grow by 7.49% this year, but quarterly earnings will post 3.90% year-over-year. Quarterly sales are estimated to shrink -13.50% in year-over-year returns.
Johnson & Johnson (JNJ) Top Institutional Holders
4,760 institutions hold shares in Johnson & Johnson (JNJ), with institutional investors hold 71.36% of the company’s shares. The shares outstanding are 2.41B, and float is at 2.40B with Short Float at 0.51%. Institutions hold 71.29% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 247.48 million shares valued at $40.96 billion. The investor’s holdings represent 9.52% of the JNJ Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 199.34 million shares valued at $33.0 billion to account for 7.67% of the shares outstanding. The other top investors are State Street Corporation which holds 141.83 million shares representing 5.46% and valued at over $23.48 billion, while Geode Capital Management, LLC holds 1.91% of the shares totaling 49.7 million with a market value of $8.23 billion.
Johnson & Johnson (JNJ) Insider Activity
A total of 0 insider transactions have happened at Johnson & Johnson (JNJ) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider sale by Taubert Jennifer L,the company’sEVP, WW Chair, Pharmaceuticals. SEC filings show that Taubert Jennifer L sold 59,397 shares of the company’s common stock on Feb 09 at a price of $156.27 per share for a total of $9.28 million. Following the sale, the insider now owns 0.14 million shares.
Johnson & Johnson disclosed in a document filed with the SEC on Jul 26 that Hait Williamsold a total of 14,698 shares of the company’s common stock. The trade occurred on Jul 26 and was made at $172.00 per share for $2.53 million. Following the transaction, the insider now directly holds 87747.0 shares of the JNJ stock.
Still, SEC filings show that on Jul 25, Fasolo Peter (Exec VP, Chief HR Officer) disposed off 20,000 shares at an average price of $170.32 for $3.41 million. The insider now directly holds 102,696 shares of Johnson & Johnson (JNJ).
Johnson & Johnson (JNJ): Who are the competitors?
The company’s main competitors (and peers) include Procter & Gamble Co. (PG) that is trading 15.80% up over the past 12 months. Rogers Corp. (ROG) that is -24.65% lower over the same period.
